Pharmaceutical combinations and methods for the treatment of leukemia
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Sep 30, 2004
app pub date -
Dec 8, 2003
filing date -
Dec 6, 2002
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
In accordance with the present invention there is provided a pharmaceutical combination useful for the treatment of leukemia comprising at least one active compound of formula (I): 1 and a Bcr-Abl tyrosine kinase inhibitor, and a method of treating a patient having leukemia comprising at least one active compound of formula (I), as defined above, and a Bcr-Abl tyrosine kinase inhibitor.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully